Evidence map›Paper›PMID 41684306›Full record

ArticleFEBS letters2026

Organ-specific redox imbalances in spinal muscular atrophy mice are partially rescued by SMN antisense oligonucleotides.

Sofia Vrettou, Brunhilde Wirth

Abstract read
In one paragraph

Article in FEBS letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Pharmacological Activation of NRF2 by Omaveloxolone Upregulates NRF2-Target Proteins in SMA Type I Human Fibroblasts.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sofia VrettouInstitute of Human Genetics, University Hospital of Cologne, University of Cologne, Germany.ORCID https://orcid.org/0000-0001-5816-8269
Brunhilde WirthInstitute of Human Genetics, University Hospital of Cologne, University of Cologne, Germany.

Funding

Center for Molecular Medicine Cologne, University of Cologne project C18European Union (EU)
6 · The paper itself

Abstract

Spinal muscular atrophy (SMA) is caused by a deficiency in survival motor neuron (SMN) protein; redox imbalance and oxidative stress are also implicated. Protein S-glutathionylation (PSSG) is a reversible redox modification that protects cysteines from irreversible oxidation and regulates protein function. Here, we report stage- and tissue-dependent defects in PSSG levels, accompanied by tissue-specific alterations in the expression of glutathione-related enzymes in Taiwanese SMA mice at early and late symptomatic stages. Importantly, we also provide evidence linking glutathione homeostasis defects with ferroptosis. Finally, partial restoration of SMN by antisense oligonucleotides selectively modulates these abnormalities in a tissue-dependent manner. Our findings suggest S-glutathionylation dysregulation as a novel SMA hallmark and highlight persistent redox imbalance as a therapeutic target beyond SMN restoration. Impact statement This study provides a multi-organ analysis of redox imbalance in spinal muscular atrophy, revealing systemic loss of protein S-glutathionylation in a stage- and tissue-dependent manner. By identifying the heart as particularly redox-vulnerable, this work refines understanding of oxidative stress beyond motor neurons and informs tissue-aware therapeutic evaluation.

Indexed as

Muscular Atrophy, SpinalOligonucleotides, AntisenseSurvival of Motor Neuron 1 ProteinAnimalsDisease Models, AnimalGlutathioneMiceOrgan SpecificityOxidation-ReductionOxidative StressGlutathioneOligonucleotides, AntisenseSurvival of Motor Neuron 1 Proteinantisense oligonucleotidesGPX4lipid peroxidationredox enzymesS‐glutathionylationSpinal muscular atrophy

Identifiers

PMID41684306
PMCPMC13502620

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.